Related Experiment Video
Updated: May 25, 2026

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC
E Kerr1, C Holohan, K M McLaughlin
1Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Northern Ireland, UK.
Abstract:
FLIP is a potential anti-cancer therapeutic target that inhibits apoptosis by blocking caspase 8 activation by death receptors. We report a novel interaction between FLIP and the DNA repair protein Ku70 that regulates FLIP protein stability by inhibiting its polyubiquitination. Furthermore, we found that the histone deacetylase (HDAC) inhibitor Vorinostat (SAHA) enhances the acetylation of Ku70, thereby disrupting the FLIP/Ku70 complex and triggering FLIP polyubiquitination and degradation by the proteasome. Using in vitro and in vivo colorectal cancer models, we further demonstrated that SAHA-induced apoptosis is dependant on FLIP downregulation and caspase 8 activation. In addition, an HDAC6-specific inhibitor Tubacin recapitulated the effects of SAHA, suggesting that HDAC6 is a key regulator of Ku70 acetylation and FLIP protein stability. Thus, HDAC inhibitors with anti-HDAC6 activity act as efficient post-transcriptional suppressors of FLIP expression and may, therefore, effectively act as 'FLIP inhibitors'.
Insights
Histone deacetylase (HDAC) inhibitors like Vorinostat disrupt the FLIP/Ku70 complex, leading to FLIP degradation and apoptosis. This reveals HDAC inhibitors as potential anti-cancer drugs by targeting FLIP expression post-transcriptionally.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- FLIP (FLICE-inhibitory protein) is a target in anti-cancer therapy, inhibiting apoptosis by blocking caspase 8 activation.
- FLIP stability is regulated by interactions with other proteins, influencing its therapeutic potential.
Purpose of the Study:
- To investigate the novel interaction between FLIP and the DNA repair protein Ku70.
- To determine the effect of histone deacetylase (HDAC) inhibitors on FLIP protein stability and apoptosis in colorectal cancer models.
Main Methods:
- Investigated the FLIP/Ku70 interaction and its effect on FLIP polyubiquitination.
- Utilized in vitro and in vivo colorectal cancer models to assess the impact of HDAC inhibitors (Vorinostat/SAHA, Tubacin).
- Analyzed FLIP downregulation, caspase 8 activation, and apoptosis induction.
Main Results:
- Identified a novel interaction between FLIP and Ku70, where Ku70 inhibits FLIP polyubiquitination, stabilizing FLIP.
- Vorinostat (SAHA) treatment enhanced Ku70 acetylation, disrupting the FLIP/Ku70 complex and promoting FLIP polyubiquitination and proteasomal degradation.
- SAHA-induced apoptosis in colorectal cancer models was dependent on FLIP downregulation and caspase 8 activation.
- HDAC6 inhibition by Tubacin mimicked SAHA's effects, highlighting HDAC6's role in Ku70 acetylation and FLIP stability.
Conclusions:
- HDAC inhibitors, particularly those targeting HDAC6, effectively suppress FLIP expression post-transcriptionally by destabilizing the FLIP/Ku70 complex.
- These findings establish HDAC inhibitors as potential 'FLIP inhibitors' and viable therapeutic agents for colorectal cancer treatment.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Anaphase Promoting Complex
Apoptosis

